Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03991819
Title Study of Binimetinib in Combination With Pembrolizumab in Advanced Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors University Health Network, Toronto

lung non-small cell carcinoma


Binimetinib + Pembrolizumab

Age Groups: senior | adult
Covered Countries CAN

Additional content available in CKB BOOST